top of page
Anne Medscape2-2023.jpg

New “Peters on Diabetes” Videos

Anne Medscape2-2023.jpg
New “Peters on Diabetes” Videos​

Dr. Peters has a new collection of her news and opinion videos from her Peters on Diabetes series that include comments from the June American Diabetes Association (ADA) meeting in San Diego.

 

These videos are announced in our X feed (formally Twitter) and Facebook page and will also be updated here as they become available. A free one-time registration on Medscape is required to view the videos.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

Shifting Focus on Obesity: Don't Forget About Glucose 
The recent American Diabetes Association meeting largely focused on obesity, leading Anne L. Peters, MD, to stress that glucose continues to matter. 

Medscape Diabetes & Endocrinology, July 14, 2023 

 

Beta Cells From Stem Cells: Nearing a Cure for Type 1 Diabetes? 
Anne L. Peters, MD, discusses clinical trial results of beta cells made from stem cells in patients with type 1 diabetes.

Medscape Diabetes & Endocrinology, June 28, 2023 

 

Automated Insulin Delivery System, Not an Artificial Pancreas  
Anne L. Peters, MD, explains why the term artificial pancreas is wrong and why automated insulin delivery system is correct. 

Medscape Diabetes & Endocrinology, May 24, 2023

 

Increased CGM Access Can Improve Treatment of T2D 
Medicare's recent decision to increase coverage of CGM for patients with type 2 diabetes who aren't on insulin is a "win-win," says Anne L. Peters, MD. 

Medscape Diabetes & Endocrinology, May 08, 2023 

 

Why the Approval of MiniMed 780G Is a 'Quantum Leap' Forward  
The FDA approval of the MiniMed 780G artificial pancreas promises better glucose control in patients with type 1 diabetes, and Dr Ann Peters is "excited" to use it with her patients. 

Medscape Diabetes & Endocrinology, April 26, 2023

 

Tidepool Loop Approval Gives More Choice in Managing T1D 
The recent FDA approval of the Tidepool Loop app offers patients with type 1 diabetes more choice in managing their disease. Anne L. Peters, MD, explains why.

Medscape Diabetes & Endocrinology, February 15, 2023

 

'Ozempic Face': Accepting Wrinkles for Improved Health 
Some who are taking Ozempic are complaining about their faces thinning as an effect of this weight loss drug. Dr Anne Peters thinks the benefit of this new medication outweighs the risk. 

Medscape Diabetes & Endocrinology, February 03, 2023

L A T E S T   N E W S

AnnePeters2023-2.jpg

MESSAGE FROM THE DIRECTOR

This era of incretin hormones, which started 15 years ago with Byetta, and has advanced through the variations Victoza,

READ MORE...

Gila_monster_ncd_2012_white_background.jpg

GLP-1

The breathless headlines about revolutionary injectable weight-loss drugs of Ozempic, Wegovy and Mounjaro and the oral version

READ MORE...

Participant1.jpg

BETA CELLS

Researchers, providers and especially people with type 1 diabetes have long wanted a cure for diabetes. Finally, there has been progress

READ MORE...

Anne Medscape2-2023.jpg

NEW “PETERS ON DIABETES” VIDEOS

Dr. Peters has a new collection of her news and opinion videos from her Peters on Diabetes series that include...,

READ MORE...

CGM2.png

SUMMER RESEARCH UPDATE

A generous multi-year grant from the Hankey Foundation allowed us to expand the team’s work to treat patients with 

READ MORE...

bottom of page